Trajectories of Metabolic Risk Factors and Biochemical Markers Prior to the Onset of Type 2 Diabetes: the Population-based Longitudinal Doetinchem Study
Overview
Nutritional Sciences
Authors
Affiliations
Background: Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding type 2 diabetes. We examined how levels and trajectories of metabolic risk factors and biochemical markers prior to diagnosis differ between persons with and without type 2 diabetes over 15-20 years.
Methods: A total of 355 incident type 2 diabetes cases (285 self-reported, 70 with random glucose ⩾11.1 mmol l) and 2130 controls were identified in a prospective cohort between 1987-2012. Risk factors were measured at 5-year intervals. Trajectories preceding case ascertainment were analysed using generalised estimating equations.
Results: Among participants with a 21-year follow-up period, those with type 2 diabetes had higher levels of metabolic risk factors and biochemical markers 15-20 years before case ascertainment. Subsequent trajectories were more unfavourable in participants with type 2 diabetes for body mass index (BMI), HDL cholesterol and glucose (P<0.01), and to a lesser extent for waist circumference, diastolic and systolic blood pressure, triglycerides, alanine aminotransferase, gamma glutamyltransferase, C-reactive protein, uric acid and estimated glomerular filtration rate compared with participants without type 2 diabetes. Among persons with type 2 diabetes, BMI increased by 5-8% over 15 years, whereas the increase among persons without type 2 diabetes was 0-2% (P<0.01). The observed differences in trajectories of metabolic risk factors and biochemical markers were largely attenuated after inclusion of BMI in the models. Results were similar for men and women.
Conclusions: Participants with diabetes had more unfavourable levels of metabolic risk factors and biochemical markers already 15-20 years before diagnosis and worse subsequent trajectories than others. Our results highlight the need, in particular, for maintenance of a healthy weight from young adulthood onwards for diabetes prevention.
Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD.
Wang J, Du J, Ge X, Peng W, Guo X, Li W Front Endocrinol (Lausanne). 2022; 13:890332.
PMID: 35712241 PMC: 9195582. DOI: 10.3389/fendo.2022.890332.
Haschka S, Gar C, Sacco V, Banning F, Ferrari U, Freibothe I BMJ Open Diabetes Res Care. 2022; 10(2).
PMID: 35241429 PMC: 8895937. DOI: 10.1136/bmjdrc-2021-002621.
Allaoui G, Rylander C, Averina M, Wilsgaard T, Fuskevag O, Berg V Endocrinol Diabetes Metab. 2022; 5(2):e00325.
PMID: 35147293 PMC: 8917864. DOI: 10.1002/edm2.325.
A Computational Method for Learning Disease Trajectories From Partially Observable EHR Data.
Oh W, Steinbach M, Castro M, Peterson K, Kumar V, Caraballo P IEEE J Biomed Health Inform. 2021; 25(7):2476-2486.
PMID: 34129510 PMC: 8388183. DOI: 10.1109/JBHI.2021.3089441.
Predicting diabetes clinical outcomes using longitudinal risk factor trajectories.
Simon G, Peterson K, Castro M, Steinbach M, Kumar V, Caraballo P BMC Med Inform Decis Mak. 2020; 20(1):6.
PMID: 31914992 PMC: 6950847. DOI: 10.1186/s12911-019-1009-3.